MNPR MONOPAR THERAPEUTICS Capital Structure Changes 8-K Filing 2024 - Financial Results and Reverse Stock Split Monopar Therapeutics announced its financial results for the second quarter of 2024 and a 1 for 5 reverse stock split of its outstanding shares of common stock.Get access to all SEC 8-K filings of the MONOPAR THERAPEUTICS